Closed-loop oxygen control for critically ill patients--A systematic review and meta-analysis.

BACKGROUND: The impact of closed-loop control systems to titrate oxygen flow in critically ill patients, including their effectiveness, efficacy, workload and safety, remains unclear. This systematic review investigated the utilization of closed-loop oxygen systems for critically ill patients in comparison to manual oxygen titration systems focusing on these topics. METHODS AND FINDINGS: A search was conducted across several databases including MEDLINE, CENTRAL, EMBASE, LILACS, CINAHL, LOVE, ClinicalTrials.gov, and the World Health Organization on March 3, 2022, with subsequent updates made on June 27, 2023. Evidence databases were searched for randomized clinical parallel or crossover studies investigating closed-loop oxygen control systems for critically ill patients. This systematic review and meta-analysis was performed following the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines. The analysis was conducted using Review Manager software, adopting the mean difference or standardized mean difference with a 95% confidence interval (95% CI) for continuous variables or risk ratio with 95% CI for dichotomous outcomes. The main outcome of interest was the percentage of time spent in the peripheral arterial oxygen saturation target. Secondary outcomes included time for supplemental oxygen weaning, length of stay, mortality, costs, adverse events, and workload of healthcare professional. A total of 37 records from 21 studies were included in this review with a total of 1,577 participants. Compared with manual oxygen titration, closed-loop oxygen control systems increased the percentage of time in the prescribed SpO2 target, mean difference (MD) 25.47; 95% CI 19.7, 30.0], with moderate certainty of evidence. Current evidence also shows that closed-loop oxygen control systems have the potential to reduce the percentage of time with hypoxemia (MD -0.98; 95% CI -1.68, -0.27) and healthcare workload (MD -4.94; 95% CI -7.28, -2.61) with low certainty of evidence. CONCLUSION: Closed-loop oxygen control systems increase the percentage of time in the preferred SpO2 targets and may reduce healthcare workload. TRIAL REGISTRATION: PROSPERO: CRD42022306033.

Closed-loop oxygen control for patients with hypoxaemia during hospitalisation: a living systematic review and meta-analysis protocol.

INTRODUCTION: Oxygen is the most common drug used in critical care patients to correct episodes of hypoxaemia. The adoption of new technologies in clinical practice, such as closed-loop systems for an automatic oxygen titration, may improve outcomes and reduce the healthcare professionals' workload at the bedside; however, certainty of the evidence regarding the safety and benefits still remains low. We aim to evaluate the effectiveness, efficacy and safety of the closed-loop oxygen control for patients with hypoxaemia during the hospitalisation period by conducting a systematic review and meta-analysis. METHODS AND ANALYSIS: MEDLINE, CENTRAL, EMBASE, LILACS, CINAHL and LOVE evidence databases will be searched. Randomised controlled trials and cross-over studies investigating the PICO (Population, Intervention, Comparator and Outcome) framework will be included. The primary outcomes will be the time in the peripheral oxygen saturation target. Secondary outcomes will include time for oxygen weaning time; length of stay; costs; adverse events; mortality; healthcare professionals' workload, and percentage of time with hypoxia and hyperoxia. Two reviewers will independently screen and extract data and perform quality assessment of included studies. The Cochrane risk of bias tool will be used to assess risk of bias. The RevMan V.5.4 software will be used for statistical analysis. Heterogeneity will be analysed using I2 statistics. Mean difference or standardised mean difference with 95% CI and p value will be used to calculate treatment effect for outcome variables. ETHICS AND DISSEMINATION: Ethical approval is not required because this systematic review and meta-analysis is based on previously published data. Final results will be published in peer-reviewed journals and presented at relevant conferences and events. PROSPERO REGISTRATION NUMBER: CRD42022306033.

Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-COVID-19 conditions: a systematic review.

QUESTION: How effective and safe is telerehabilitation for people with COVID-19 and post-COVID-19 conditions? DESIGN: Systematic review of randomised trials. PARTICIPANTS: People with COVID-19 and post-COVID-19 conditions. INTERVENTION: Any type of telerehabilitation. OUTCOME MEASURES: Satisfaction, quality of life, adverse events, adherence to telerehabilitation, dyspnoea, functional performance, readmissions, mortality, pulmonary function and level of independence. RESULTS: Database searches retrieved 2,962 records, of which six trials with 323 participants were included in the review. Breathing exercises delivered via telerehabilitation improved 6-minute walk distance (MD 101 m, 95% CI 61 to 141; two studies), 30-second sit-to-stand test performance (MD 2.2 repetitions, 95% CI 1.5 to 2.8; two studies), Multidimensional Dyspnoea-12 questionnaire scores (MD -6, 95% CI -7 to -5; two studies) and perceived effort on the 0-to-10 Borg scale (MD -2.8, 95% CI -3.3 to -2.3; two studies), with low certainty of evidence. Exercise delivered via telerehabilitation improved 6-minute walk distance (MD 62 m, 95% CI 42 to 82, four studies), 30-second sit-to-stand test performance (MD 2.0 repetitions, 95% CI 1.3 to 2.7; two studies) and Multidimensional Dyspnoea-12 scores (MD -1.8, 95% CI -2.5 to -1.1; one study), with low certainty of evidence. Adverse events were almost all mild or moderate and occurred with similar frequency in the telerehabilitation group (median 0 per participant, IQR 0 to 2.75) as in the control group (median 0 per participant, IQR 0 to 2); Hodges-Lehmann median difference 0 (95% CI 0 to 0), with low certainty of evidence. CONCLUSION: Telerehabilitation may improve functional capacity, dyspnoea, performance and physical components of quality of life and does not substantially increase adverse events. REGISTRATION: PROSPERO CRD42021271049.

Determinação do risco cardiovascular em adultos jovens universitários / Determination of cardiovascular risk in young adults university students

O objetivo deste estudo foi determinar o risco cardiovascular em uma população de adultos jovens universitários que frequentam os cursos de Educação Física e Fisioterapia na Universidade Federal do Amazonas utilizando o Escore de Framingham e o Escore de Risco Global. Trata-se de um estudo observacional transversal onde foram avaliados 63 indivíduos de ambos os sexos com 20-30 anos. Os métodos de avaliação incluíram questionário, análise antropométrica e coleta sanguínea para realização dos exames bioquímicos. Para determinação do risco cardiovascular foram utilizados os escores de Framingham (ERF) e Risco Global (ERG) para uma idade modificada de 65 anos. As análises estatísticas foram descritivas (média, desvio-padrão, frequência simples e percentagem). O Teste t de Student foi aplicado para comparação entre grupos (p<0,05). O ERF identificou, entre o sexo masculino 23,53% com baixo risco e 76,47% com risco intermediário para desenvolvimento de doença cardiovascular nos próximos 10 anos. Todas as mulheres apresentaram baixo risco. O ERG demonstrou que entre os homens, 94,12% apresentaram risco intermediário e 5,88% alto risco, e dentre as mulheres 63,04% estavam na faixa de baixo risco e 36,96% risco intermediário. Os resultados demonstram a ocorrência de níveis intermediários no desenvolvimento de DCV na população de adultos jovens nos próximos 10 anos figurando-os como alvo imediato de ações preventivas.

The objective of this study was to determine the cardiovascular risk in a population of young university students attending the courses of Physical Education and Physiotherapy at the Federal University of Amazonas using the Framingham Score and the Global Risk Score. It is a cross-sectional observational study in which 63 individuals of both sexes with 20-30 years were evaluated. Methods of evaluation included questionnaire, anthropometric analysis and blood collection for biochemical tests. The Framingham (FRE) and Global Risk (GRE) scores for a modified age of 65 years were used to determine cardiovascular risk. Statistical analyzes were descriptive (mean, standard deviation, simple frequency and percentage). Student's t-test was applied for comparison between groups (p <0.05). The FRE identified 23.53% of men with low risk and 76.47% with intermediate risk for cardiovascular disease in the next 10 years. All women were at low risk. The GRE showed that among the men, 94.12% presented intermediate risk and 5.88% high risk, and among the women 63.04% were in the low risk range and 36.96% intermediate risk. The results demonstrate the occurrence of intermediate levels in the development of CVD in the population of young adults in the next 10 years, as an immediate target for preventive actions.